Toll Free: 1-888-928-9744
Published: May, 2014 | Pages:
32 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Senju Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Senju Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Senju Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Senju Pharmaceutical Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Senju Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Senju Pharmaceutical Co., Ltd.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Senju Pharmaceutical Co., Ltd.'s pipeline products Reasons to buy - Evaluate Senju Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Senju Pharmaceutical Co., Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Senju Pharmaceutical Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Senju Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Senju Pharmaceutical Co., Ltd. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Senju Pharmaceutical Co., Ltd. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Senju Pharmaceutical Co., Ltd. Snapshot 5 Senju Pharmaceutical Co., Ltd. Overview 5 Key Information 5 Key Facts 5 Senju Pharmaceutical Co., Ltd. - Research and Development Overview 6 Key Therapeutic Areas 6 Senju Pharmaceutical Co., Ltd. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Senju Pharmaceutical Co., Ltd. - Pipeline Products Glance 12 Senju Pharmaceutical Co., Ltd. - Late Stage Pipeline Products 12 Phase III Products/Combination Treatment Modalities 12 Senju Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Senju Pharmaceutical Co., Ltd. - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 Senju Pharmaceutical Co., Ltd. - Drug Profiles 15 bromfenac sodium 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 difluprednate 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 SJP-0035 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 SNJ-1656 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 SNJ-1945 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Senju Pharmaceutical Co., Ltd. - Pipeline Analysis 21 Senju Pharmaceutical Co., Ltd. - Pipeline Products by Target 21 Senju Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration 22 Senju Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type 23 Senju Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action 24 Senju Pharmaceutical Co., Ltd. - Recent Pipeline Updates 25 Senju Pharmaceutical Co., Ltd. - Dormant Projects 26 Senju Pharmaceutical Co., Ltd. - Company Statement 27 Senju Pharmaceutical Co., Ltd. - Locations And Subsidiaries 28 Head Office 28 Other Locations & Subsidiaries 28 Senju Pharmaceutical Co., Ltd. - Key Manufacturing Facilities 30 Appendix 31 Methodology 31 Coverage 31 Secondary Research 31 Primary Research 31 Expert Panel Validation 31 Contact Us 32 Disclaimer 32
List of Tables Senju Pharmaceutical Co., Ltd., Key Information 5 Senju Pharmaceutical Co., Ltd., Key Facts 5 Senju Pharmaceutical Co., Ltd. - Pipeline by Indication, 2014 7 Senju Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014 8 Senju Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014 9 Senju Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2014 10 Senju Pharmaceutical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 11 Senju Pharmaceutical Co., Ltd. - Phase III, 2014 12 Senju Pharmaceutical Co., Ltd. - Phase II, 2014 13 Senju Pharmaceutical Co., Ltd. - Preclinical, 2014 14 Senju Pharmaceutical Co., Ltd. - Pipeline by Target, 2014 21 Senju Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2014 22 Senju Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2014 23 Senju Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2014 24 Senju Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2014 25 Senju Pharmaceutical Co., Ltd. - Dormant Developmental Projects,2014 26 Senju Pharmaceutical Co., Ltd., Other Locations 28 Senju Pharmaceutical Co., Ltd., Subsidiaries 29 Senju Pharmaceutical Co., Ltd., Key Manufacturing Facilities 30
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.